Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Oxford Immunotec (OXFD)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 474,762
  • Shares Outstanding, K 26,361
  • Annual Sales, $ 59,750 K
  • Annual Income, $ 121,280 K
  • 60-Month Beta 0.36
  • Price/Sales 8.03
  • Price/Cash Flow N/A
  • Price/Book 6.57

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/19
See More
  • Average Estimate -0.20
  • Number of Estimates 3
  • High Estimate -0.15
  • Low Estimate -0.27
  • Prior Year -0.40
  • Growth Rate Est. (year over year) +50.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
15.10 +19.21%
on 03/13/19
18.60 -3.23%
on 03/15/19
+1.25 (+7.46%)
since 02/19/19
3-Month
11.88 +51.52%
on 12/24/18
18.60 -3.23%
on 03/15/19
+4.92 (+37.61%)
since 12/19/18
52-Week
11.66 +54.37%
on 07/30/18
19.19 -6.20%
on 09/25/18
+4.45 (+32.84%)
since 03/19/18

Most Recent Stories

More News
Zacks.com featured highlights include: Great Lakes, Oxford Immunotec, DSP, Telenav and Osisko

Zacks.com featured highlights include: Great Lakes, Oxford Immunotec, DSP, Telenav and Osisko

OXFD : 17.96 (-0.28%)
OR : 11.63 (+2.02%)
GLDD : 8.54 (+0.47%)
DSPG : 14.20 (+0.07%)
TNAV : 6.63 (+4.08%)
5 Great Breakout Stocks Offering Stunning Returns

Selecting breakout stocks is probably one of the most favored techniques among active investors.

OXFD : 17.96 (-0.28%)
OR : 11.63 (+2.02%)
GLDD : 8.54 (+0.47%)
DSPG : 14.20 (+0.07%)
TNAV : 6.63 (+4.08%)
Moving Average Crossover Alert: Oxford Immunotec Global

Oxford Immunotec Global PLC (OXFD) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front.

OXFD : 17.96 (-0.28%)
Best Relative Performance in the Health Care Equipment Industry Detected in Shares of Tandem Diabetes (TNDM, OXFD , DXCM , IDXX , EW )

Here are the top 5 stocks in the Health Care Equipment industry ranked by performance. We compiled the trading activity from yesterday and then analyzed the industry looking for stocks that were outperforming....

OXFD : 17.96 (-0.28%)
TNDM : 71.58 (+0.38%)
DXCM : 146.40 (+0.17%)
Oxford Immunotec (OXFD) Beats Q4 Earnings Estimates

Oxford Immunotec (OXFD) delivered earnings and revenue surprises of 757.89% and -17.43%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?

OXFD : 17.96 (-0.28%)
Oxford Immunotec: 4Q Earnings Snapshot

ABINGDON, Britain (AP) _ Oxford Immunotec Global PLC (OXFD) on Monday reported fourth-quarter earnings of $141.6 million.

OXFD : 17.96 (-0.28%)
Oxford Immunotec Reports Fourth Quarter and Full Year 2018 Financial Results

OXFORD, United Kingdom and MARLBOROUGH, Mass., March 11, 2019 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq: OXFD) (the "Company"), a global, high-growth diagnostics company, today announced...

OXFD : 17.96 (-0.28%)
Oxford Immunotec Global PLC to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / March 11, 2019 / Oxford Immunotec Global PLC (NASDAQ: ) will be discussing their earnings results in their 2018 Fourth Quarter Earnings to be held on March 11, 2019 at 4:30...

OXFD : 17.96 (-0.28%)
Oxford Immunotec to Participate in Two Upcoming Investor Conferences

OXFORD, United Kingdom and MARLBOROUGH, Mass., March 05, 2019 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, high-growth diagnostics company, today announced that Dr. Peter...

OXFD : 17.96 (-0.28%)
Oxford Immunotec Schedules Fourth Quarter and Full Year 2018 Earnings Release and Conference Call for March 11, 2019

OXFORD, United Kingdom and MARLBOROUGH, Mass., Feb. 19, 2019 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq:OXFD) (the "Company"), a global, high-growth diagnostics company, today announced...

OXFD : 17.96 (-0.28%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade OXFD with:

Business Summary

Oxford Immunotec Global PLC is a medical diagnostics company. It develops new tests for various diseases based on its, patented T cell measurement technology. The company's first product is the T-SPOT(R). Oxford Immunotec Global PLC is headquartered in Abingdon, the United Kingdom.

See More

Key Turning Points

2nd Resistance Point 18.63
1st Resistance Point 18.32
Last Price 17.96
1st Support Level 17.81
2nd Support Level 17.61

See More

52-Week High 19.19
Last Price 17.96
Fibonacci 61.8% 16.31
Fibonacci 50% 15.43
Fibonacci 38.2% 14.54
52-Week Low 11.66

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar